Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

License Agreement With Duke - Additional Information (Detail)

License Agreement With Duke - Additional Information (Detail)				12 Months Ended
	Feb. 17, 2023 USD ($)	Feb. 04, 2022 USD ($)	Feb. 23, 2021 USD ($)	Nov. 30, 2022 USD ($) ft² shares	Nov. 30, 2021 USD ($)	Feb. 23, 2023 USD ($)	Feb. 28, 2021 USD ($)	Dec. 01, 2020 USD ($)
Patent Option Agreement [Line Items]
Revenue				$ 30,336,749	$ 28,884,902
Duke University [Member]
Patent Option Agreement [Line Items]
License fee payable						$ 2,000,000		$ 12,000,000
Milestone payment		$ 2,000,000	$ 2,000,000
Capitalized costs to obtain agreement							$ 15,372,382
Present value of license fee				12,000,000
Number of common stock value transferred				$ 3,585,172
Number of common stock shares transferred \| shares				409,734
Capitalized costs amortization period				16 years
Amortization expense				$ 960,774	$ 720,580
Duke University [Member] \| 5.0% upon Execution of the Agreement [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage			5.00%
Duke University [Member] \| 2.5% Market Cap [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage			2.50%
Duke University [Member] \| Minimum [Member]
Patent Option Agreement [Line Items]
Royalties Percentage Portion of Net Sales			7.00%
Duke University [Member] \| Minimum [Member] \| 2.5% Market Cap Triggers with 18 Months [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Average Closing Market Capital			$ 300,000,000
Duke University [Member] \| Minimum [Member] \| 2.5% Market Cap Triggers with 24 Months [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Average Closing Market Capital			$ 500,000,000
Duke University [Member] \| Maximum [Member]
Patent Option Agreement [Line Items]
Royalties Percentage Portion of Net Sales			12.50%
Duke University [Member] \| Within Fourteen (14) days of February 23, 2021
Patent Option Agreement [Line Items]
License fee payable			$ 10,000,000
Duke University [Member] \| Second Anniversary [Member]
Patent Option Agreement [Line Items]
Minimum Annual Royalties Due Year Two			500,000
Minimum Annual Royalties Due Year Three			1,000,000
Minimum Annual Royalties Due Year Four			2,500,000
Minimum Annual Royalties Due Year Five			5,000,000
Minimum Annual Royalties Due After Year Five			$ 5,000,000
Duke University [Member] \| Third Anniversary [Member]
Patent Option Agreement [Line Items]
Minimum Annual Royalties Due Year Three		500,000
Minimum Annual Royalties Due Year Four		1,000,000
Minimum Annual Royalties Due Year Five		2,500,000
Minimum Annual Royalties Due Year Six		5,000,000
Minimum Annual Royalties Due After Year Six		$ 5,000,000
Duke University [Member] \| Licensed Product and Licensed Process [Member]
Patent Option Agreement [Line Items]
Area of medical condominium building \| ft²				56,000
Royalties Term				15 years
Duke University [Member] \| Licensed Product and Licensed Process [Member] \| 2.5% Upon Cumulative Net Sales [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage			2.50%
Revenue			$ 10,000,000
Duke University [Member] \| Licensed Product and Licensed Process [Member] \| 2.5% Upon Cumulative Net Sales [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage			2.50%
Revenue			$ 75,000,000
Second Amendment to the License Agreement [Member]
Patent Option Agreement [Line Items]
Milestone payment	$ 1,000,000
Research Agreement [Member]
Patent Option Agreement [Line Items]
Monthly instalment payable	187,407
Consideration payable for research	$ 187,400